文献速递心脑血管急症创伤与烧伤重症综合管理与镇静镇痛

创伤性大脑静脉窦血栓形成的临床特征、管理与结局

Clinical characteristics, management, and outcomes of traumatic cerebral venous sinus thrombosis.
PubMed 文献 · J Trauma Acute Care Surg · 2025-09-15
一句话结论创伤性大脑静脉窦血栓形成(CVST)在重型颅脑损伤中患病率4.8%,标准VTE预防剂量抗凝治疗患者中未见症状性CVST相关不良事件。

该回顾性队列研究纳入2014年1月至2023年10月单中心收治的创伤患者,评估创伤性CVST的患病率、特征、管理与结局。CVST总体患病率0.9%,TBI患者中2.1%,重型TBI患者中4.8%。170例CVST患者中28例(16.5%)死亡,多发生在入院后不久;100例接受标准VTE预防剂量抗凝治疗的患者中,随访中位3个月期间无一例发生症状性CVST相关不良事件,1例(1.0%)无症状性CVST相关卒中,3例(3.0%)无症状性CVST进展,3例(3.0%)抗凝期间消化道出血。作者结论认为创伤性CVST患病率随颅脑创伤严重程度增加,无颅骨骨折时不太可能发生;标准VTE预防剂量抗凝治疗患者结局良好,CVST相关并发症少;需更长期数据评估预后。

要点

  • 创伤性CVST总体患病率0.9%(95%CI 0.8-1.0),TBI患者中2.1%(95%CI 1.9-2.5),重型TBI(改良头部简明损伤定级≥4)患者中4.8%(95%CI 4.0-5.8)。
  • 170例CVST患者入院时均有TBI和颅内出血,除1例外均有颅骨骨折,提示无颅骨骨折时不太可能发生CVST。
  • 28例CVST患者死亡(16.5%),通常发生在入院后不久。
  • 100例CVST患者住院期间接受标准VTE预防剂量抗凝治疗,随访中位3个月期间无一例发生症状性CVST相关不良事件(死亡、卒中、颅内出血)。
  • 接受抗凝治疗的100例中,1例(1.0%)无症状性CVST相关卒中,3例(3.0%)无症状性CVST进展,3例(3.0%)消化道出血。

适用人群与场景

  • 2014年1月至2023年10月入住一级创伤中心的创伤患者(n=18,569)。
  • CVST患者(n=170)入院时均有创伤性脑损伤(TBI)和颅内出血,除1例外均有颅骨骨折。

处置流程与药物剂量

  • CVST患者中多数(n=100)住院期间接受标准静脉血栓栓塞症(VTE)预防剂量抗凝治疗。

研究设计与关键结果

  • 回顾性队列研究,单中心,纳入创伤患者18,569例,其中CVST 170例。
  • CVST患病率:总体创伤人群0.9%(95%CI 0.8-1.0),TBI患者(n=7,920)2.1%(95%CI 1.9-2.5),重型TBI(改良头部简明损伤定级≥4,n=2,035)4.8%(95%CI 4.0-5.8)。
  • 170例CVST患者中28例死亡(16.5%),通常发生在入院后不久。
  • 100例接受标准VTE预防剂量抗凝治疗的CVST患者,随访中位3个月期间无一例发生症状性CVST相关不良事件(死亡、卒中、颅内出血);1例(1.0%)无症状性CVST相关卒中,3例(3.0%)无症状性CVST进展,3例(3.0%)抗凝期间消化道出血。

证据类型、等级与局限

  • 证据类型:回顾性队列研究;预后与流行病学证据等级IV级。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者结论认为,创伤性CVST患病率随颅脑创伤严重程度增加,无颅骨骨折时不太可能发生。
  • 作者结论认为,接受标准VTE预防剂量抗凝治疗的患者结局良好,住院期间CVST相关并发症极少。
  • 作者结论认为,需更长期数据以更好地评估创伤性CVST预后。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Traumatic cerebral venous sinus thrombosis (CVST) is abnormal clotting in one or more cerebral veins or sinuses following trauma. Its clinical significance is uncertain. Management is challenging because patients are at increased risk for bleeding. Limited studies exist on traumatic CVST.

METHODS: Retrospective cohort study of trauma patients admitted to a Level 1 trauma center between January 2014 and October 2023. Main objectives were to assess the following: (1) CVST prevalence, overall and according to head injury severity; (2) characteristics of trauma patients with CVST; and (3) management and outcomes of CVST patients.

RESULTS: On admission, all CVST patients (n = 170) had a traumatic brain injury (TBI) and an intracranial hemorrhage, and all except one had a skull fracture. Prevalence of CVST was 0.9% (95% confidence interval [CI], 0.8-1.0) in the overall trauma patient population (n = 18,569), 2.1% (95% CI, 1.9-2.5) in patients with TBI (n = 7,920), and 4.8% (95% CI, 4.0-5.8) in patients with severe TBI (modified head Abbreviated Injury Scale score, ≥4; n = 2,035). Twenty-eight patients with CVST died (16.5%), usually shortly after admission. The majority of patients (n = 100) with CVST were treated with standard venous thromboembolism (VTE) prophylactic dose of anticoagulant while in hospital. During median follow-up of 3 months, none of the patients treated with standard VTE prophylactic dose of anticoagulant developed a symptomatic CVST-related adverse event (death, stroke, intracranial hemorrhage). One patient (1.0%) had asymptomatic CVST-related stroke, three patients (3.0%) developed asymptomatic CVST extension, and 3 patients (3.0%) developed a gastrointestinal bleed on anticoagulant.

CONCLUSION: Traumatic CVST prevalence increases with head trauma severity and is unlikely to develop in the absence of skull fracture. Patients treated with standard VTE prophylactic doses of anticoagulants had favorable outcomes with minimal CVST-related complications during hospitalization. Longer-term data are needed to better evaluate traumatic CVST prognosis.

LEVEL OF EVIDENCE: Prognostic and Epidemiological; Level IV.

来源:J Trauma Acute Care Surg,查看原文。版权归原作者所有。

参考来源

  1. Kapitanski L, Thiyagarajah K, Makedonov I, et al. Clinical characteristics, management, and outcomes of traumatic cerebral venous sinus thrombosis. J Trauma Acute Care Surg. 2025. PMID: 40956305. doi:10.1097/TA.0000000000004774

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。